GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicines
1 May 2012 | By GlaxoSmithKline
GSK and Yale University have established a drug discovery research collaboration...
List view / Grid view
News
Biosimilars webinar presented by Catalent expert for the pharmaceutical education and research institute
1 May 2012 | By Catalent Pharma Solutions
Carolyn Finkle at Catalent to present webinar...
Pall expands single-use solutions portfolio with new products at INTERPHEX 2012
1 May 2012 | By Pall Life Sciences
Pall Corporation will introduce five new single-use products at INTERPHEX 2012...
Pfizer and Protalix BioTherapeutics announce FDA approval Of ELELYSO™ (taliglucerase alfa)
1 May 2012 | By Pfizer
The U.S. FDA has approved ELELYSO™...
Gilead initiates Phase 3 clinical trial evaluating GS-1101 for the treatment of chronic lymphocytic leukemia
1 May 2012 | By Gilead Sciences
Gilead Sciences announced that the first patient has been dosed in a Phase 3 clinical trial...
Teva settles Nuvigil litigation with Mylan
30 April 2012 | By Teva Pharmaceutical Industries Ltd
TEVA, has settled patent infringement litigation with Mylan Inc.'s ANDA for Teva’s wakefulness product NUVIGIL® (armodafinil) tablets...
BASF relocates production of Kolliphor TPGS to its Minden site
30 April 2012 | By
BASF will transfer the pharmaceutical production of KolliphorTM TPGS to its Minden facility...
Algeta and Sanofi extend research collaboration evaluating thorium-conjugated tumor-targeting antibody
30 April 2012 | By Citigate Dewe Rogerson
Algeta ASA announces that its research collaboration with Sanofi has been extended...
Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals
29 April 2012 | By Boehringer Ingelheim
New data on TWYNSTA®...
Syrris Asia Chip Climate Controller – advanced microreactor temperature control
27 April 2012 | By kdm communications limited
Syrris offers the unique Asia Chip Climate Controller module for its revolutionary range...
Japan chooses Sanofi Pasteur for first enhanced Inactivated Polio Vaccine
27 April 2012 | By Sanofi
Approval of IMOVAX® POLIO by Japanese health authorities...
AstraZeneca needs new strategy after boardroom shake up – EP Vantage investigates
27 April 2012 | By AstraZeneca
As AstraZeneca PLC Chief Executive David Brennan steps down...
Catalent case study presented on achieving Biological Assay
Michael Merges, Director of Biopharmaceutical Support Services, and Michael Sadick, Ph.D., Senior Manager of Biopharmaceutical Characterization, Development and Analytical Services, Catalent Pharma Solutions, will be presenting “Bioassay Development Basics 101,” at the Biological Assay Development, Validation & Maintenance Conference in Boston, MA on Monday, April 30, 2012, at 1:30 p.m.
Merck wins U.S. ZETIA® (ezetimibe) / VYTORIN® (ezetimibe/simvastatin) patent infringement lawsuit
27 April 2012 | By Merck
"The court appropriately ruled that the patent for ZETIA and VYTORIN in the U.S. is valid..."
Novo Nordisk A/S expects to elect new chairman in 2013
27 April 2012 | By Novo Nordisk
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation...
